2.2. Participants
renal or hepatic failure, allergic reaction
ALLERGIC REACTION, COVID-19 INFECTION
Confirmed cases of COVID-19 patients were eligible for this trial if they were 18 years and older, referred to any of the outpatient settings of the study in the first seven days of their symptoms, and had an oxygen saturation of 93% or more on room air. Cases of severe COVID-19 who had criteria for hospitalization, pregnant or breastfeeding women, patients with renal or hepatic failure, patients who were under treatment with corticosteroids, patients with a previous history of COVID-19 infection, those who received any antiviral medication within two weeks before the first dose of the study treatment, and those with a possible allergic reaction to Favipiravir were excluded.